Intraoral scanners are used by orthodontics to capture 3D images of the dentition and soft tissue of intraoral areas. The images obtained from intraoral scanners are of superior quality as compared to conventional methods, leading to high-quality treatment results.
The global intraocular lens market generated $273 million in 2016, and is projected to reach $557 million by 2023, registering a CAGR of 10.7% during the study period. In terms of volume, the market is expected to grow at a CAGR of 15.4%. The global intraoral scanners market is driven by increase in geriatric population and rise in the number of patients suffering from dental disorders. Moreover, benefits of intraoral scanners, such as ease of handling, lightweight, and high precision of images further boost the market growth. However, high cost of the devices and dearth of skilled professionals restrain the market growth.
The global intraoral scanners market is segmented on the basis of brand, end user, and region. Based on brand, it is divided into Cadent iTero, 3M ESPE Lava COS, CEREC, E4D, TRIOS, CS, and others. On the basis of end user, it is classified into hospitals, dental clinics and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key market players operating in this market include 3M Company, 3Shape A/S, Align Technology, Inc., Carestream Health Inc., Condor International, Densys3D Ltd., Dental Wings Inc., Dentsply Sirona Inc., Planmeca OY, and Guangdong Launca Medical Device Technology Co. Ltd.
KEY BENEFITS FOR STAKEHOLDERS
KEY MARKET SEGMENTS
By End User
The key players profiled in this report are as follows
Cephalosporin Market by Generation (First-generation, Second-generation, Third-generation, Fourth-generation, and Fifth-generation), Type (Branded and Generics), Route of Drug Administration (Injection and Oral), and Application (Respiratory Tract Infection, Skin Infection, Ear Infection, Urinary Tract Infection, and Sexually Transmitted Infection) - Global Opportunity Analysis and Industry Forecast, 2017-2023
Cephalosporin is a group of semisynthetic, broad-spectrum antibiotics, which is majorly used to treat bacterial infections. It resembles penicillin and hence is used as an alternative for patients who are allergic to penicillin. It is used in the treatment of a variety of clinical conditions, including pneumonia, skin infections, strep ...
November 2017 | $5370 |View Details>>
The Global Drugs for Malaria market size will be XX million (USD) in 2022, from the XX million (USD) in 2016, with a CAGR (Compound Annual Growth Rate) of XX% from between 2016 and 2022. This report studies the global Drugs for Malaria market, especially in North America, Europe, Asia-Pacific, South ...
November 2017 | $4960 |View Details>>
In 2016, the Asia-Pacific Drugs for Malaria market size was xx million USD and it will reach xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. This report studies Drugs for Malaria in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, India, Australia, Indonesia, Thailand and ...
November 2017 | $4660 |View Details>>
In 2016, the Drugs for Malaria market size was xx million USD in China, and it will be xx million USD in 2022, with a CAGR of xx% between 2016 and 2022. In China market, the top players include Cipla Guilin Pharmaceutical ...
November 2017 | $3360 |View Details>>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research